Phenotypic and genotypie testing of HSV-1 resistance to antivirals

Methods in Molecular Biology

Volumn 1144, Issue , 2014, Pages 149-165

  Sauerbrei, Andreas ^a   Bohn, Kathrin ^a  

^a NONE

Author keywords

DNA polymerase; Genotypic resistance; Herpes simplex virus; Phenotypic resistance; Thymidine kinase

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; BRINCIDOFOVIR; DNA FRAGMENT; DNA POLYMERASE; PNEUMOCOCCUS VACCINE; THYMIDINE KINASE;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CELL SUSPENSION; CONTROLLED STUDY; ELECTROPHORESIS; FRAMESHIFT MUTATION; GENETIC ANALYSIS; GENOTYPE; HERPES SIMPLEX VIRUS 1; HUMAN; IC50; INHIBITORY CONCENTRATION; LUNG FIBROBLAST; MOLECULAR WEIGHT; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENE; VIRUS INFECTIVITY;

EID: 84940987225     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0428-010     Document Type: Article

References (22)

1. Frobert E, Cortay JC, Ooka T, Najioullah F, Thouvenot D, Lina B, Morfin F (2008) Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res 79:28-36
2. Morfin F, Thouvenot D (2003) Herpes simplex virus resistance to antiviral drugs. J Clin Virol 26:29-37
3. Stránská R, Schuurman R, Scholl DR, Jollick JA, Shaw CJ, Loef C, Polman M, van Loon AM (2004) ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing. Antimicrob Agents Chemother 48:2331-2333
4. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D (2003) Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 16:114-128
5. Morfin F, Souillet G, Bilger K, Ooka T, Aymard M, Thouvenot D (2000) Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J Infect Dis 182:290-293
6. Burrel S, Deback C, Agut H, Boutolleau D (2010) Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother 54:4833-4842
7. Bohn K, Zell R, Schacke M, Wutzler P, Sauerbrei A (2011) Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus. Antiviral Ther 16:989-997
8. Bestman-Smith J, Schmitt I, Papadopoulou B, Boivin G (2001) Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J Virol 75:3105-3110
9. Larder BA, Darby G (1985) Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing alter-ated DNA polymerase activities. Virology 146:262-271
10. Chibo D, Druce J, Sasadeusz J, Birch C (2004) Molecular analysis of clinical isolates of acyclo-vir resistant herpes simplex virus. Antiviral Res 61:83-91
11. Piret J, Boivin G (2011) Resistance of herpes simplex virus to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55:459-472
12. Sajo M, Suzutani T, De Clercq E, Niikura M, Maeda A, Morikawa S, Kurane I (2002) Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Antiviral Res 56:253-262
13. Sauerbrei A, Deinhardt S, Zell R, Wutzler P (2010) Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus. Antiviral Res 86:246-252
14. Sauerbrei A, Bohn K, Heim A, Hofmann J, Weifibrich B, Schnitzler P, Hoffmann D, Zell R, Jahn G, Wutzler P, Hamprecht K (2011) Novel resistance-associated mutations of the thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2. Antiviral Ther 16:1297-1308
15. McGeoch DJ, Dolan A, Donald S, Rixon FJ (1985) Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol 181:1-13
16. Spearman C (1908) The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae. Br J Psychol 2:227-242
17. Kaerber G (1931) Beitrag zur Kollektiven Behandlung Pharmakologischer Reihenversuche [A contribution to the collective treatment of a pharmacological experimental series]. Arch Exp Pathol Pharmakol 162:480-483
18. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewjin P, Desmyter J, De Clercq E (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti- HIV compounds. J Virol Methods 20:309-321
19. Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J, Kessler HA, Landry B, Mills J (1991) A controlled trial comparing foscar-net with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med 325:551-555
20. Sauerbrei A, Liermann K, Bohn K, Henke A, Zell R, Gronowitz S, Wutzler P (2012) Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance. Antiviral Res 96:105-107
21. Sauerbrei A, Eichhorn U, Hottenrott G, Wutzler P (2000) Virological diagnosis of herpes simplex encephalitis. J Clin Virol 17:31-36
22. Suzutani T, Ishioka K, De Clercq E, Ishibashi K, Kaneko H, Kira T, Hashimoto K, Ogasawara M, Ohtani K, Wakamiya N, Saijo M (2003) Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob Agents Chemother 47:1707-1713